Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Int J Womens Dermatol ; 3(4): 231-233, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29234719

ABSTRACT

Erythema nodosum (EN) is a septal panniculitis that is characterized clinically by tender, erythematous, subcutaneous nodules that are predominately localized on the pretibial lower legs. EN affects women more than men and can be idiopathic or secondary to another disease process such as infection or an immune response. Treatment options for erythema nodosum are suboptimal and often involve significant side effects or require a change in lifestyle. We investigated the effects of moderate 20 mmHg to 30 mmHg compression stockings as an alternative treatment method in two female patients with recurrent erythema nodosum. In both cases, the patients wore the compression stockings daily. At the follow-up visit, the EN lesions were no longer tender to the touch, and postinflammatory hyperpigmentation changes had started. Both patients had a lasting clinical resolution.

2.
Br J Cancer ; 111(9): 1718-25, 2014 Oct 28.
Article in English | MEDLINE | ID: mdl-25144625

ABSTRACT

BACKGROUND: The Combined Aerobic and Resistance Exercise Trial tested different types and doses of exercise in breast cancer patients receiving chemotherapy. Here, we explore potential moderators of the exercise training responses. METHODS: Breast cancer patients initiating chemotherapy (N=301) were randomly assigned to three times a week, supervised exercise of a standard dose of 25-30 min of aerobic exercise, a higher dose of 50-60 min of aerobic exercise, or a higher dose of 50-60 min of combined aerobic and resistance exercise. Outcomes were patient-reported symptoms and health-related fitness. Moderators were baseline demographic, exercise/fitness, and cancer variables. RESULTS: Body mass index moderated the effects of the exercise interventions on bodily pain (P for interaction=0.038), endocrine symptoms (P for interaction=0.029), taxane/neuropathy symptoms (P for interaction=0.013), aerobic fitness (P for interaction=0.041), muscular strength (P for interaction=0.007), and fat mass (P for interaction=0.005). In general, healthy weight patients responded better to the higher-dose exercise interventions than overweight/obese patients. Menopausal status, age, and baseline fitness moderated the effects on patient-reported symptoms. Premenopausal, younger, and fitter patients achieved greater benefits from the higher-dose exercise interventions. CONCLUSIONS: Healthy weight, fitter, and premenopausal/younger breast cancer patients receiving chemotherapy are more likely to benefit from higher-dose exercise interventions.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/rehabilitation , Exercise Therapy/methods , Quality of Life , Chemotherapy, Adjuvant , Exercise Therapy/classification , Female , Follow-Up Studies , Humans , Middle Aged , Motor Activity , Patient Compliance , Prognosis
3.
J Chemother ; 12(4): 360-6, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10949987

ABSTRACT

Mechanisms of chemoresistance in renal cell carcinoma include P-glycoprotein, overexpression of multidrug resistance-1 (mdr1) gene, and unstable chromosomal aberrations. In vitro exposure of resistant tumor cells to low dose hydroxyurea causes loss of chromosomal aberrations, decrease in the mdr1 gene copies, and increased sensitivity to vinblastine. Patients received continuous hydroxyurea 500 mg every Monday, Wednesday and Friday. Vinblastine 5 mg/m2 was given intravenously on days 1 and 8 every 21 days. Seventeen patients with a median age of 63 (range 40-80) received a median of 3 courses of vinblastine (range 1-14). Toxicities included: > or = grade 3 non-hematologic toxicity (1) and febrile neutropenia (2). No treatment related mortality occurred. Three patients (17.6%) had partial responses. The median survival was 38.0 weeks (95% CI = 26.9-49.1 weeks). The addition of hydroxyurea given at the dose of 500 mg orally three times weekly had no major impact on the expected antitumor effect of vinblastine.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Renal Cell/metabolism , Drug Resistance, Neoplasm , Hydroxyurea/pharmacology , Kidney Neoplasms/metabolism , ATP Binding Cassette Transporter, Subfamily B/metabolism , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Carcinoma, Renal Cell/drug therapy , Carcinoma, Renal Cell/genetics , Carcinoma, Renal Cell/secondary , Chromosome Aberrations , Female , Humans , Hydroxyurea/administration & dosage , Hydroxyurea/therapeutic use , Kidney Neoplasms/drug therapy , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Male , Middle Aged , Outcome Assessment, Health Care , Pilot Projects , Vinblastine/pharmacology , Vinblastine/therapeutic use
4.
Cutis ; 61(1): 34-6, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9466080

ABSTRACT

Traumatic tattoos result from accidental deposition of pigmented particles in the dermis. Battery-operated devices should be added to the list of situations in which traumatic tattoos may arise. In this case, an iron-containing tattoo was removed by Mohs' micrographic surgery with an acceptable cosmetic result.


Subject(s)
Ear, External/injuries , Tattooing/adverse effects , Adult , Ear, External/pathology , Ear, External/surgery , Female , Humans , Mohs Surgery
6.
Dermatol Surg ; 21(2): 175-6, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7894941

ABSTRACT

BACKGROUND: A cup to transport resterilizable electrodes is introduced. OBJECTIVE: To prevent loss of durable resterilizable electrodes, to increase awareness of workplace hazards in the physician's office, and to minimize needle stick injuries. METHODS: The cup described is a readily available surgical receptacle. The resterilizable electrodes were provided by Hasting's Biomedical Corporation. The system was developed and evaluated in clinical practice. RESULTS: The transport cup has been found to reduce loss of resterilizable electrodes in a dermatology office. Its use is welcomed by the nursing staff as a method to reduce handling of contaminated electrodes. The system described also eliminates staff handling of sharp electrosurgical needles. CONCLUSIONS: An efficient method of using the stainless steel transport cup is described that greatly improves office safety and prevents loss of durable electrosurgical electrodes.


Subject(s)
Electrodes , Electrosurgery/instrumentation , Sterilization/instrumentation , Equipment Contamination , Stainless Steel , Sterilization/methods
7.
Am J Forensic Med Pathol ; 6(3): 274-5, 1985 Sep.
Article in English | MEDLINE | ID: mdl-3870682

ABSTRACT

We report a case which was processed by the Philadelphia Office of the Medical Examiner in which a person with a previous known suicide attempt clearly provoked the Philadelphia police into shooting him. We believe that this is but one of many such incidents in which the victim provokes another into administering fatal injury. This is a mechanism of suicide which, we believe, is exemplified by the case presented.


Subject(s)
Social Control, Formal , Suicide , Humans , Male
8.
Int J Dermatol ; 18(8): 639-44, 1979 Oct.
Article in English | MEDLINE | ID: mdl-389841

ABSTRACT

Five cases of cutaneous sporotrichosis were seen at the Stanford University Department of Dermatology from 1966 to 1977, where the disease was previously unreported. The possibility of sporotrichosis should be considered when suppurative cutaneous lesions do not respond to antibacterial agents. Skin biopsy of sporotrichotic lesion is often nonspecific, while culture is the best method of diagnosis.


Subject(s)
Dermatomycoses/diagnosis , Sporothrix/isolation & purification , Sporotrichosis/diagnosis , Adult , Aged , Child, Preschool , Dermatomycoses/drug therapy , Dermatomycoses/immunology , Female , Fluorescent Antibody Technique , Hot Temperature/therapeutic use , Humans , Male , Middle Aged , Potassium Iodide/therapeutic use , Sporotrichosis/drug therapy , Sporotrichosis/immunology
9.
Arch Dermatol ; 115(3): 334-5, 1979 Mar.
Article in English | MEDLINE | ID: mdl-434851

ABSTRACT

A patient had numerous cysts over almost all of his skin surface. The lesions were persistently infected, painful, and odorous, and were contributory to the patient's psychological problems. The cysts were histologically determined to be of the steatocystoma multiplex variety. Several therapeutic modalities were used but only surgical incision, drainage, and electrocautery were beneficial.


Subject(s)
Epidermal Cyst/pathology , Epidermal Cyst/psychology , Epidermal Cyst/surgery , Humans , Male , Middle Aged
11.
Arch Dermatol ; 114(7): 1067-9, 1978 Jul.
Article in English | MEDLINE | ID: mdl-210713

ABSTRACT

Kaposi's varicelliform eruption, caused by herpes simplex type 1, developed in a patient with mycosis fungoides four days after initiation of photochemotherapy with methoxsalen plus long-wave ultraviolet light (PUVA). He had a history of recurrent localized herpes infection. Vidarabine (adenine arabinoside) was used as treatment. Rechallenge with PUVA did not provoke another herpes infection. Kaposi's varicelliform eruption is rare in mycosis fungoides. Vidarabine may prove to be useful in the treatment of widespread herpes simplex.


Subject(s)
Kaposi Varicelliform Eruption/complications , Methoxsalen/adverse effects , Mycosis Fungoides/complications , Photochemotherapy/adverse effects , Skin Neoplasms/complications , Humans , Kaposi Varicelliform Eruption/drug therapy , Kaposi Varicelliform Eruption/immunology , Kaposi Varicelliform Eruption/microbiology , Male , Methoxsalen/therapeutic use , Middle Aged , Mycosis Fungoides/therapy , Simplexvirus , Skin Neoplasms/therapy , Ultraviolet Therapy , Vidarabine/therapeutic use
12.
Am J Ophthalmol ; 86(1): 133-5, 1978 Jul.
Article in English | MEDLINE | ID: mdl-354393

ABSTRACT

A 53-year-old woman, treated in the acute phase of Stevens-Johnson syndrome, received one drop of proparacaine hydrochloride 0.5% in each eye for topical anesthesia. One hour later she developed new bullae of the hands and feet.


Subject(s)
Anesthetics, Local/adverse effects , Skin Diseases, Vesiculobullous/chemically induced , Stevens-Johnson Syndrome/chemically induced , Conjunctivitis/chemically induced , Conjunctivitis/therapy , Diphenhydramine/adverse effects , Female , Furosemide/adverse effects , Humans , Middle Aged , Ophthalmic Solutions , Reserpine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...